![]() | |||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||
| |||||||||||||||||||||||||
![]() |
Products: COVID-19 Test |
![]() |
![]() Status™ COVID-19/Flu A&B - Rapid SARS-CoV-2/Influenza A+B Antigen Panel Test A rapid, Point of Care immunochromatographic assay for the simultaneous qualitative detection and differentiation of nucleocapsid antigen from SARS-CoV-2, influenza A and influenza B directly from nasopharyngeal swab specimens obtained from individuals, who are suspected of respiratory viral infection consistent with COVID-19 by their healthcare provider, within the first five days of onset of symptoms. FDA Emergency Use Authorization for Use in CLIA Waived Settings Influenza Annual Reactivity Testing Data (2018-2019-2020) [PDF, 138 KB] Highlights
|
![]() |
Important EUA Documents |
![]() |
Instructions for Use [PDF] |
Quick Reference Instructions [PDF] |
Fact Sheet for Patients [PDF] |
Fact Sheet for Healthcare Providers [PDF] |
![]() |
![]() |
![]() |
All contents copyright © 1997-2015 Princeton BioMeditech Corporation. All rights reserved. Terms of Use |